Investment

Sirona's role as a partner to private equity firms, for example, is crucial to identify and analyze the key value drivers in specific companies and create the most value for patients, society and investors.

Sirona is active in all parts of the investment cycle and we have acted as a partner to Private Equity companies operating in healthcare and life science for many years. The work consists of identifying acquisition candidates in the early stages through sector mapping and market screening. We have extensive experience in commercial due diligence (CDD) of concrete acquisition objects, and also vendor due diligence (VDD) in the event of divestment/exit. During the holding period, we also help with post-acquisition projects such as 100-day programs and business development for the portfolio companies at all different levels from strategy, M&A to business development.

What makes us an attractive partner during the investment phase is that we have experience in all subsectors of healthcare and life sciences. This, combined with our large network of experts; which includes everything from senior physicians, marketing experts to regional directors, means that we have deep sector-specific expertise. This brings added value when it comes to identifying and analyzing the issues that are the key value drivers for sectors as a whole and for specific companies in particular. Healthcare and life sciences is a complex sector and our understanding of the system as a whole and the differences across countries provides an enhanced understanding of where in the value chain a company fits and has the opportunity to create the most value for patients, taxpayers and investors.